Cullinan Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-98,900
| Closed | -$4.32M | – | 183 |
|
|
2020
Q1 | $4.32M | Sell |
98,900
-5,800
| -6% | -$254K | 0.35% | 75 |
|
|
2019
Q4 | $5.26M | Buy |
104,700
+6,650
| +7% | +$334K | 0.35% | 79 |
|
|
2019
Q3 | $4.54M | Buy |
98,050
+7,225
| +8% | +$335K | 0.32% | 80 |
|
|
2019
Q2 | $3.93M | Buy |
90,825
+4,650
| +5% | +$201K | 0.29% | 86 |
|
|
2019
Q1 | $3.82M | Buy |
86,175
+9,675
| +13% | +$428K | 0.29% | 91 |
|
|
2018
Q4 | $3.32M | Sell |
76,500
-4,300
| -5% | -$187K | 0.27% | 90 |
|
|
2018
Q3 | $3.61M | Sell |
80,800
-6,250
| -7% | -$279K | 0.26% | 96 |
|
|
2018
Q2 | $3.48M | Sell |
87,050
-3,600
| -4% | -$144K | 0.27% | 94 |
|
|
2018
Q1 | $3.63M | Sell |
90,650
-500
| -0.5% | -$20K | 0.28% | 93 |
|
|
2017
Q4 | $3.92M | Buy |
91,150
+11,950
| +15% | +$514K | 0.29% | 91 |
|
|
2017
Q3 | $3.94M | Buy |
79,200
+7,300
| +10% | +$363K | 0.3% | 85 |
|
|
2017
Q2 | $3.45M | Buy |
71,900
+7,900
| +12% | +$379K | 0.27% | 92 |
|
|
2017
Q1 | $2.9M | Buy |
64,000
+3,340
| +6% | +$151K | 0.24% | 100 |
|
|
2016
Q4 | $2.45M | Buy |
+60,660
| New | +$2.45M | 0.21% | 109 |
|